共 13 条
[1]
multitargeted antifolateLY231514as first-line chemotherapy for patients with advanced non-small-cell lung cancer:aphaseⅡstudy. Rusthoven JJ,Eisenhauer E,Butts C,et al. Journal of Clinical Oncology . 1999
[5]
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. Hanna N, Shepherd FA, Fossella FV, et al. Journal of Clinical Oncology . 2004
[6]
Plosker GL Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer. Curran MP. Drugs and Aging . 2002
[7]
美国FDA批准培美曲塞加顺铂联合治疗恶性胸膜间皮瘤. 世界临床医药 . 2004
[8]
PhaseⅢstudy comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. Scagliotti GV,Parikh P,von Pawel J,Biesma B,Vansteenkiste J,Manegold C,Serwatowski P,Gatzemeier U,Digumarti R,Zukin M,Lee JS,Mellemgaard A,Park K,Patil S,Rolski J,Goksel T,de Marinis F,Simms L,Sugarman KP,Gandara D. Journal of Clinical Oncology . 2008
[9]
PhaseⅡtrial of peme-trexed disodium in chemotherapy-naive patients with advanced non-small-cell lung cancer. Clarke SJ,Abratt R,Goedhals L,et al. Am Oncol . 2002
[10]
Lung cancer in the elderly. Gridelli C, Perrone F, Monfardini S. European Journal of Cancer . 1997